207 related articles for article (PubMed ID: 11994226)
1. Androgen receptor CAG repeats and prostate cancer.
Nelson KA; Witte JS
Am J Epidemiol; 2002 May; 155(10):883-90. PubMed ID: 11994226
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
[TBL] [Abstract][Full Text] [Related]
4. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
5. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
Beilin J; Ball EM; Favaloro JM; Zajac JD
J Mol Endocrinol; 2000 Aug; 25(1):85-96. PubMed ID: 10915221
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
Hakimi JM; Schoenberg MP; Rondinelli RH; Piantadosi S; Barrack ER
Clin Cancer Res; 1997 Sep; 3(9):1599-608. PubMed ID: 9815849
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor CAG repeat: a modifier of carcinogenesis?
Ferro P; Catalano MG; Dell'Eva R; Fortunati N; Pfeffer U
Mol Cell Endocrinol; 2002 Jul; 193(1-2):109-20. PubMed ID: 12161010
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.
Hardy DO; Scher HI; Bogenreider T; Sabbatini P; Zhang ZF; Nanus DM; Catterall JF
J Clin Endocrinol Metab; 1996 Dec; 81(12):4400-5. PubMed ID: 8954049
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
13. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
15. South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.
Krishnaswamy V; Kumarasamy T; Venkatesan V; Shroff S; Jayanth VR; Paul SFD
J Hum Genet; 2006; 51(3):254-257. PubMed ID: 16437189
[TBL] [Abstract][Full Text] [Related]
16. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
[TBL] [Abstract][Full Text] [Related]
19. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
[TBL] [Abstract][Full Text] [Related]
20. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
